Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy
Your Content Goes Here Deoxysphingolipids (1-deoxySLs) are neurotoxic [...]
Heterozygous mutations in SOX2 may cause idiopathic hypogonadotropic hypogonadism via dominant-negative mechanisms
Your Content Goes Here Pathogenic SRY-box transcription factor [...]
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma
Your Content Goes Here Neurofibromatosis 2 (NF2) is [...]
CHIPping away at cardiovascular disease
Your Content Goes Here Clonal hematopoiesis of indeterminate [...]
Analysis of genetic dominance in the UK Biobank
Your Content Goes Here For many monogenic traits, [...]
Diverse data expand what’s known about IBD genetics
Your Content Goes Here Inflammatory bowel diseases (IBDs) [...]
Sweet genetics
Your Content Goes Here The limited information regarding [...]
Cardiometabolic profiles in children and adults with overweight and obesity and down syndrome
Your Content Goes Here Being obese is associated [...]
Precise DNA cleavage using CRISPR-SpRYgests
Your Content Goes Here The ability to precisely [...]
A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage
Your Content Goes Here Intracerebral hemorrhage (ICH) is [...]
The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.
